Hypopharyngeal Carcinoma

• CLINICAL_TRIALS trial_result · 2026-06-03
  Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]

  Phase 2/3 trial evaluating atezolizumab and/or bevacizumab with or without standard chemotherapy as second-line treatment for advanced head …

• CLINICAL_TRIALS trial_result · 2025-12-23
  Clinical Trial Update: Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma [Phase 2]

  Phase 2 trial evaluating neoadjuvant chemotherapy combined with finotonlimab for locally advanced hypopharyngeal carcinoma is currently recr…

• CLINICAL_TRIALS research · 2025-12-19
  Clinical Trial Update: Salvage Surgery in Recurrent Hypopharyngeal Carcinoma: an Observational Single-institutional Study From 1998

  This is an observational, single-institution study from 1998 evaluating salvage surgery for recurrent hypopharyngeal carcinoma.

• CLINICAL_TRIALS research · 2025-05-08
  Clinical Trial Update: Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma [Phase 3]

  A Phase 3 trial is evaluating neoadjuvant chemotherapy with a PD-1 inhibitor versus neoadjuvant chemotherapy alone for locally advanced lary…

• CLINICAL_TRIALS trial_result · 2023-08-09
  Clinical Trial Update: Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma [Phase 2]

  Phase 2 trial exploring induction chemotherapy combined with immunotherapy for locally advanced hypopharyngeal carcinoma.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.